It has been experimentally demonstrated that Zaragozionic acid, a pharmacological inhibitor of Squalene synthase (SQS), can lead to growth arrest and induction of cytotoxicity in prostate cancer cells (Brusselmans et al., 2007). Here, FDFT1 is linked to prostate cancer.